{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:47:06Z","timestamp":1768175226901,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40271-025-00768-0","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:50:39Z","timestamp":1757425839000},"page":"51-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Literature Review of Preference Studies in Migraine Treatments"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4953-0472","authenticated-orcid":false,"given":"Divya","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6061-4301","authenticated-orcid":false,"given":"Jaein","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"2","key":"768_CR1","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/j.pain.0000000000002275","volume":"163","author":"S Safiri","year":"2022","unstructured":"Safiri S, Pourfathi H, Eagan A, Mansournia MA, Khodayari MT, Sullman MJM, et al. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022;163(2):e293\u2013309. https:\/\/doi.org\/10.1097\/j.pain.0000000000002275.","journal-title":"Pain"},{"issue":"10127","key":"768_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","volume":"391","author":"DW Dodick","year":"2018","unstructured":"Dodick DW. Migraine. Lancet. 2018;391(10127):1315\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(18)30478-1.","journal-title":"Lancet"},{"issue":"11","key":"768_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, et al. Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954\u201376.","journal-title":"Lancet Neurol"},{"issue":"10283","key":"768_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Buse DC, Ashina H, Pozo-Rosich P, Peres MF, Lee MJ, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021;397(10283):1505\u201318.","journal-title":"Lancet"},{"issue":"8","key":"768_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener H-C, Mitsikostas DD, Sinclair AJ, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501\u201314.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"768_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/head.13456","volume":"59","author":"American Headache Society","year":"2019","unstructured":"American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1\u201318. https:\/\/doi.org\/10.1111\/head.13456.","journal-title":"Headache"},{"issue":"10283","key":"768_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485\u201395.","journal-title":"Lancet"},{"key":"768_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-018-0839-1","volume":"19","author":"Z Katsarava","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe\u2013evidence from the Eurolight study. J Headache Pain. 2018;19:1\u20139.","journal-title":"J Headache Pain"},{"issue":"5","key":"768_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"},{"key":"768_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/PPA.S24752","volume":"6","author":"C Dias-Barbosa","year":"2012","unstructured":"Dias-Barbosa C, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39\u201348. https:\/\/doi.org\/10.2147\/PPA.S24752.","journal-title":"Patient Prefer Adherence"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40273-014-0170-x","volume":"32","author":"MD Clark","year":"2014","unstructured":"Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32:883\u2013902.","journal-title":"Pharmacoeconomics"},{"key":"768_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","volume":"26","author":"E Lancsar","year":"2008","unstructured":"Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user\u2019s guide. Pharmacoeconomics. 2008;26:661\u201377.","journal-title":"Pharmacoeconomics"},{"key":"768_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","volume":"37","author":"V Soekhai","year":"2019","unstructured":"Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37:201\u201326.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"768_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.31138\/mjr.32.2.104","volume":"32","author":"S Zartab","year":"2021","unstructured":"Zartab S, Nikfar S, Karimpour-Fard N, Jamshidi A, Varahrami V, Homayouni A, Kebriaeezadeh A. A systematic review of discrete choice experiment studies in rheumatoid arthritis biological medicines. Mediterr J Rheumatol. 2021;32(2):104\u201311. https:\/\/doi.org\/10.31138\/mjr.32.2.104.","journal-title":"Mediterr J Rheumatol"},{"key":"768_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101507","author":"LPL Wulandari","year":"2022","unstructured":"Wulandari LPL, He SY, Fairley CK, Bavinton BR, Schmidt H-M, Wiseman V, et al. Preferences for pre-exposure prophylaxis for HIV: a systematic review of discrete choice experiments. EClinicalMedicine. 2022. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101507.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"768_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40271-021-00520-4","volume":"14","author":"H Collacott","year":"2021","unstructured":"Collacott H, Soekhai V, Thomas C, Brooks A, Brookes E, Lo R, et al. A systematic review of discrete choice experiments in oncology treatments. Patient. 2021;14(6):775\u201390. https:\/\/doi.org\/10.1007\/s40271-021-00520-4.","journal-title":"Patient"},{"issue":"1","key":"768_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40273-022-01198-8","volume":"41","author":"S Jiang","year":"2023","unstructured":"Jiang S, Ren R, Gu Y, Jeet V, Liu P, Li S. Patient preferences in targeted pharmacotherapy for cancers: a systematic review of discrete choice experiments. Pharmacoeconomics. 2023;41(1):43\u201357. https:\/\/doi.org\/10.1007\/s40273-022-01198-8.","journal-title":"Pharmacoeconomics"},{"key":"768_CR18","doi-asserted-by":"publisher","DOI":"10.2196\/56546","volume":"10","author":"Y Huang","year":"2024","unstructured":"Huang Y, Feng S, Zhao Y, Wang H, Jiang H. Preferences for COVID-19 vaccines: systematic literature review of discrete choice experiments. JMIR Public Health Surveill. 2024;10: e56546. https:\/\/doi.org\/10.2196\/56546.","journal-title":"JMIR Public Health Surveill"},{"key":"768_CR19","unstructured":"Nested Knowledge. Nested Knowledge platform [Internet]. https:\/\/about.nested-knowledge.com\/."},{"key":"768_CR20","doi-asserted-by":"publisher","first-page":"9919773","DOI":"10.1155\/2021\/9919773","volume":"2021","author":"X Xu","year":"2021","unstructured":"Xu X, Ji Q, Shen M. Patient preferences and values in decision making for migraines: a systematic literature review. Pain Res Manag. 2021;2021:9919773. https:\/\/doi.org\/10.1155\/2021\/9919773.","journal-title":"Pain Res Manag"},{"key":"768_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-025-01495-y","author":"SPH Nouwens","year":"2025","unstructured":"Nouwens SPH, Marceta SM, Bui M, van Dijk D, Groothuis-Oudshoorn CGM, Veldwijk J, et al. The evolving landscape of discrete choice experiments in health economics: a systematic review. Pharmacoeconomics. 2025. https:\/\/doi.org\/10.1007\/s40273-025-01495-y.","journal-title":"Pharmacoeconomics"},{"key":"768_CR22","volume-title":"Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme version I","author":"J Popay","year":"2006","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme version I. University of Lancaster; 2006."},{"key":"768_CR23","unstructured":"European Medicines Agency. Qualification opinion of IMI PREFER 2022. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/qualification-opinion-imi-prefer_en.pdf."},{"key":"768_CR24","unstructured":"The PREFER Consortium. Recommendations - Why, when and how to assess and use patient preferences in medical product decision-making 2022. https:\/\/zenodo.org\/record\/6491042#.YnLPTofMI2x."},{"key":"768_CR25","unstructured":"US Food and Drug Administration. Guidance for industry: patient preference information \u2013 Voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling 2016. https:\/\/www.fda.gov\/media\/92593\/download."},{"issue":"5","key":"768_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40271-017-0235-y","volume":"10","author":"DR Bien","year":"2017","unstructured":"Bien DR, Danner M, Vennedey V, Civello D, Evers SM, Hiligsmann M. Patients\u2019 preferences for outcome, process and cost attributes in cancer treatment: a systematic review of discrete choice experiments. Patient. 2017;10(5):553\u201365. https:\/\/doi.org\/10.1007\/s40271-017-0235-y.","journal-title":"Patient"},{"issue":"1","key":"768_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40271-021-00536-w","volume":"15","author":"H Collacott","year":"2022","unstructured":"Collacott H, Zhang D, Heidenreich S, Tervonen T. A systematic and critical review of discrete choice experiments in asthma and chronic obstructive pulmonary disease. Patient. 2022;15(1):55\u201368. https:\/\/doi.org\/10.1007\/s40271-021-00536-w.","journal-title":"Patient"},{"key":"768_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1472-6963-14-367","volume":"14","author":"KL Mandeville","year":"2014","unstructured":"Mandeville KL, Lagarde M, Hanson K. The use of discrete choice experiments to inform health workforce policy: a systematic review. BMC Health Serv Res. 2014;14:367. https:\/\/doi.org\/10.1186\/1472-6963-14-367.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"768_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.MLR.0000044909.63278.0D","volume":"41","author":"LA Lenert","year":"2003","unstructured":"Lenert LA. Use of willingness to pay to study values for pharmacotherapies for migraine headache. Med Care. 2003;41(2):299\u2013308. https:\/\/doi.org\/10.1097\/01.MLR.0000044909.63278.0D.","journal-title":"Med Care"},{"key":"768_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/head.14974","author":"RB Lipton","year":"2025","unstructured":"Lipton RB, Gandhi P, Myers K, Bussberg C, Stokes J, Nahas SJ. Patient preferences for the preventive treatment of episodic migraine in the United States: a discrete-choice experiment. Headache. 2025. https:\/\/doi.org\/10.1111\/head.14974.","journal-title":"Headache"},{"issue":"3","key":"768_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/head.14255","volume":"62","author":"J Ailani","year":"2022","unstructured":"Ailani J, Winner P, Hartry A, Brevig T, Bog M, Lassen AB, et al. Patient preference for early onset of efficacy of preventive migraine treatments. Headache. 2022;62(3):374\u201382. https:\/\/doi.org\/10.1111\/head.14255.","journal-title":"Headache"},{"issue":"10","key":"768_CR32","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/head.12142","volume":"53","author":"JM Gonzalez","year":"2013","unstructured":"Gonzalez JM, Johnson FR, Runken MC, Poulos CM. Evaluating migraineurs\u2019 preferences for migraine treatment outcomes using a choice experiment. Headache. 2013;53(10):1635\u201350. https:\/\/doi.org\/10.1111\/head.12142.","journal-title":"Headache"},{"issue":"2","key":"768_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1468-2982.2005.00797.x","volume":"25","author":"SW Hamelsky","year":"2005","unstructured":"Hamelsky SW, Lipton RB, Stewart WF. An assessment of the burden of migraine using the willingness to pay model. Cephalalgia. 2005;25(2):87\u2013100. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.00797.x.","journal-title":"Cephalalgia"},{"issue":"5","key":"768_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/head.13498","volume":"59","author":"C Mansfield","year":"2019","unstructured":"Mansfield C, Gebben DJ, Sutphin J, Tepper SJ, Schwedt TJ, Sapra S, Shah N. Patient preferences for preventive migraine treatments: a discrete-choice experiment. Headache. 2019;59(5):715\u201326. https:\/\/doi.org\/10.1111\/head.13498.","journal-title":"Headache"},{"issue":"4","key":"768_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/head.14476","volume":"63","author":"TJ Schwedt","year":"2023","unstructured":"Schwedt TJ, Martin A, Kymes S, Talon B, Lee XY, Cady R, et al. Patient preferences for attributes of injected or infused preventive migraine medications: findings from a discrete choice experiment. Headache. 2023;63(4):484\u201393. https:\/\/doi.org\/10.1111\/head.14476.","journal-title":"Headache"},{"key":"768_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/PPA.S496736","volume":"19","author":"C Whichello","year":"2025","unstructured":"Whichello C, Viktrup L, Varnado OJ, Quaife M, Trapali M, Tockhorn-Heidenreich A. Patient preferences for episodic migraine medications: a discrete choice experiment of self-injectable versus oral treatments targeting calcitonin gene-related peptide pathway. Patient Prefer Adherence. 2025;19:839\u201353. https:\/\/doi.org\/10.2147\/PPA.S496736.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"768_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40120-023-00453-0","volume":"12","author":"J Seo","year":"2023","unstructured":"Seo J, Tervonen T, Ueda K, Zhang D, Danno D, Tockhorn-Heidenreich A. Discrete choice experiment to understand Japanese patients\u2019 and physicians\u2019 preferences for preventive treatments for migraine. Neurol Ther. 2023;12(2):651\u201368. https:\/\/doi.org\/10.1007\/s40120-023-00453-0.","journal-title":"Neurol Ther"},{"issue":"6","key":"768_CR38","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s40120-024-00663-0","volume":"13","author":"T Takeshima","year":"2024","unstructured":"Takeshima T, Yuasa A, Lloyd YM, Watanabe LP, Kamei K, Terasawa A, et al. A discrete-choice experiment assessing the patient preferences and real-world experiences of patients with migraine in Japan. Neurol Ther. 2024;13(6):1661\u201383. https:\/\/doi.org\/10.1007\/s40120-024-00663-0.","journal-title":"Neurol Ther"},{"issue":"1","key":"768_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/head.14781","volume":"65","author":"JK Bougie","year":"2025","unstructured":"Bougie JK, Krupsky K, Beusterien K, Ladouceur MP, Mulvihill E. Patient preferences for preventive migraine treatments among Canadian adults: a discrete choice experiment. Headache. 2025;65(1):113\u201323. https:\/\/doi.org\/10.1111\/head.14781.","journal-title":"Headache"},{"key":"768_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094916","author":"A Torbica","year":"2021","unstructured":"Torbica A, Rognoni C, Tarricone R. Investigating patients\u2019 preferences to inform drug development decisions: novel insights from a discrete choice experiment in migraine. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18094916.","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"768_CR41","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s11136-019-02163-3","volume":"28","author":"LS Matza","year":"2019","unstructured":"Matza LS, Deger KA, Vo P, Maniyar F, Goadsby PJ. Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences. Qual Life Res. 2019;28(9):2359\u201372. https:\/\/doi.org\/10.1007\/s11136-019-02163-3.","journal-title":"Qual Life Res"},{"key":"768_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10194-011-0398-1","volume":"13","author":"C Lampl","year":"2012","unstructured":"Lampl C, Steiner TJ, Mueller T, Mirvelashvili E, Djibuti M, Kukava M, et al. Will (or can) people pay for headache care in a poor country? J Headache Pain. 2012;13:67\u201374.","journal-title":"J Headache Pain"},{"issue":"4","key":"768_CR43","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1526-4610.2007.00757.x","volume":"47","author":"MF Peres","year":"2007","unstructured":"Peres MF, Silberstein S, Moreira F, Corchs F, Vieira DS, Abraham N, Gebeline-Myers C. Patients\u2019 preference for migraine preventive therapy. Headache. 2007;47(4):540\u20135. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00757.x.","journal-title":"Headache"},{"issue":"9","key":"768_CR44","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/head.14386","volume":"62","author":"LT Hubig","year":"2022","unstructured":"Hubig LT, Smith T, Chua GN, Lloyd AJ, Powell L, Johnston K, et al. A stated preference survey to explore patient preferences for novel preventive migraine treatments. Headache. 2022;62(9):1187\u201397. https:\/\/doi.org\/10.1111\/head.14386.","journal-title":"Headache"},{"issue":"10","key":"768_CR45","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/ejp.1831","volume":"25","author":"P Pozo-Rosich","year":"2021","unstructured":"Pozo-Rosich P, Gil-Gouveia R, Donnet A, Poole AC, Gendolla A, Afridi S, et al. Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey. Eur J Pain. 2021;25(10):2177\u201389. https:\/\/doi.org\/10.1002\/ejp.1831.","journal-title":"Eur J Pain"},{"issue":"4","key":"768_CR46","doi-asserted-by":"publisher","first-page":"A147","DOI":"10.1016\/j.jval.2012.03.795","volume":"15","author":"JM Gonzalez","year":"2012","unstructured":"Gonzalez JM, Hauber AB, Levitan B, Coplan P. PND36 Structured benefit\u2013risk assessment of triptan treatments using patient-preference data. Value Health. 2012;15(4):A147.","journal-title":"Value Health."},{"issue":"4","key":"768_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1526-4610.1998.3804295.x","volume":"38","author":"P Jhingran","year":"1998","unstructured":"Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the migraine-specific quality of life questionnaire. Headache. 1998;38(4):295\u2013302. https:\/\/doi.org\/10.1046\/j.1526-4610.1998.3804295.x.","journal-title":"Headache"},{"issue":"6 Suppl 1","key":"768_CR48","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/wnl.56.suppl_1.s20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138. https:\/\/doi.org\/10.1212\/wnl.56.suppl_1.s20.","journal-title":"Neurology"},{"issue":"2","key":"768_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1590\/S1980-57642012DN06020002","volume":"6","author":"CM de Araujo","year":"2012","unstructured":"de Araujo CM, Barbosa IG, Lemos SMA, Domingues RB, Teixeira AL. Cognitive impairment in migraine: a systematic review. Dement Neuropsychol. 2012;6(2):74\u20139. https:\/\/doi.org\/10.1590\/S1980-57642012DN06020002.","journal-title":"Dement Neuropsychol"},{"issue":"5","key":"768_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40271-024-00693-8","volume":"17","author":"C Vass","year":"2024","unstructured":"Vass C, Boeri M, Shields G, Seo J. Making use of technology to improve stated preference studies. Patient. 2024;17(5):483\u201391. https:\/\/doi.org\/10.1007\/s40271-024-00693-8.","journal-title":"Patient"},{"issue":"4","key":"768_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JF Bridges","year":"2011","unstructured":"Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403\u201313. https:\/\/doi.org\/10.1016\/j.jval.2010.11.013.","journal-title":"Value Health"},{"issue":"3","key":"768_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hec.1369","volume":"18","author":"M Ryan","year":"2009","unstructured":"Ryan M, Watson V, Entwistle V. Rationalising the \u2018irrational\u2019: a think aloud study of discrete choice experiment responses. Health Econ. 2009;18(3):321\u201336. https:\/\/doi.org\/10.1002\/hec.1369.","journal-title":"Health Econ"},{"issue":"1","key":"768_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-018-0324-6","volume":"12","author":"D Campbell","year":"2019","unstructured":"Campbell D, Erdem S. Including opt-out options in discrete choice experiments: issues to consider. Patient. 2019;12(1):1\u201314. https:\/\/doi.org\/10.1007\/s40271-018-0324-6.","journal-title":"Patient"},{"issue":"6","key":"768_CR54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0272989X19862275","volume":"39","author":"D Determann","year":"2019","unstructured":"Determann D, Gyrd-Hansen D, de Wit GA, de Bekker-Grob EW, Steyerberg EW, Lambooij MS, Bjornskov PL. Designing unforced choice experiments to inform health care decision making: implications of using opt-out, neither, or status quo alternatives in discrete choice experiments. Med Decis Making. 2019;39(6):681\u201392. https:\/\/doi.org\/10.1177\/0272989X19862275.","journal-title":"Med Decis Making"},{"issue":"11","key":"768_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111805","volume":"9","author":"J Veldwijk","year":"2014","unstructured":"Veldwijk J, Lambooij MS, de Bekker-Grob EW, Smit HA, de Wit GA. The effect of including an opt-out option in discrete choice experiments. PLoS ONE. 2014;9(11): e111805. https:\/\/doi.org\/10.1371\/journal.pone.0111805.","journal-title":"PLoS ONE"},{"issue":"10","key":"768_CR56","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s40273-024-01431-6","volume":"42","author":"J Ride","year":"2024","unstructured":"Ride J, Goranitis I, Meng Y, LaBond C, Lancsar E. A reporting checklist for discrete choice experiments in health: the DIRECT checklist. Pharmacoeconomics. 2024;42(10):1161\u201375. https:\/\/doi.org\/10.1007\/s40273-024-01431-6.","journal-title":"Pharmacoeconomics"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-025-00768-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:06:06Z","timestamp":1768165566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-025-00768-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s40271-025-00768-0","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Divya Mohan, Harrison Clarke, Natasha Ramachandran, and Jaein Seo have no conflicts of interest to declare relevant to this study. Jaein Seo previously received funding from Eli Lilly to conduct a preference study on treatments for migraine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests"}},{"value":"The data extracted and\/or analyzed during the study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statements"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"D.M. contributed to the analysis and interpretation of data and drafting of the manuscript. H.C. contributed to abstract and full-text screening of studies, data extraction, analysis of data, and drafting of the manuscript. N.R. contributed to abstract and full-text screening of studies, data extraction, analysis of the extracted data, and critical review of the manuscript. J.S. contributed to the study conception and design, abstract and full-text screening of studies for inclusion, data extraction, analysis and interpretation of data, and drafting and critical review of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}